Literature DB >> 16429105

Neonatal Diabetes Mellitus -- genetic aspects 2004.

Michel Polak1, Julian Shield.   

Abstract

Transient (TNDM) and Permanent (PNDM) Neonatal Diabetes Mellitus are rare conditions occurring in 1:400,000-500,000 live births. In TNDM growth retarded infants develop diabetes in the first few weeks of life only to go into remission in a few months with possible relapse to a permanent diabetes state usually around adolescence or as adults. We believe that pancreatic dysfunction in this condition is maintained throughout life with relapse initiated at times of metabolic stress such as puberty or pregnancy. In PNDM, insulin secretory failure occurs in the late fetal or early post-natal period. A number of conditions are associated with PNDM, some of which have been elucidated at the molecular levels Among those, the very recently elucidated mutations in KCNJ11 gene, encoding the Kir6.2 subunit of the pancreatic KATP channel involved in regulation of insulin secretion accounts for one third to a half of the PNDM cases.

Entities:  

Mesh:

Year:  2004        PMID: 16429105

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  4 in total

1.  Permanent neonatal diabetes due to KCNJ11 gene mutation.

Authors:  S Letha; Darly Mammen; Joseph J Valamparampil
Journal:  Indian J Pediatr       Date:  2007-10       Impact factor: 1.967

Review 2.  Neonatal diabetes mellitus.

Authors:  Lydia Aguilar-Bryan; Joseph Bryan
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

3.  Neonatal diabetes with intractable epilepsy: DEND syndrome.

Authors:  Poonam Singh; Sudha Chandrashekhar Rao; Ruchi Parikh
Journal:  Indian J Pediatr       Date:  2014-06-10       Impact factor: 1.967

4.  The clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar.

Authors:  Sara Al-Khawaga; Idris Mohammed; Saras Saraswathi; Basma Haris; Reem Hasnah; Amira Saeed; Hakeem Almabrazi; Najeeb Syed; Puthen Jithesh; Ahmed El Awwa; Amal Khalifa; Fawziya AlKhalaf; Goran Petrovski; Essam M Abdelalim; Khalid Hussain
Journal:  Mol Genet Genomic Med       Date:  2019-08-23       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.